See this official SEC document? On page 146 Elon Musk revealed the name of a startup that Jeff believes will be…

Even though this has nothing to do with robots, self-driving cars, or rockets…

This startup is growing faster than Tesla… faster than SpaceX… and even 23 times faster than Nvidia.

That's why The Atlantic called it…

"The fastest-growing business in the history of capitalism." (Click here to get the name, 100% free of charge.)

I Keep the Rich Young for a Living
A longevity-clinic tech in Florida on the new divide — the people who age, and the people who pay not to.
 
TRANSMISSION
From: Dana Whitfield, Naples, Florida
Date: March 14, 2045
Subject: The people who age, and the people who don't

My mother died Tuesday.

She was 79. Her heart, they said. It just wore out. The old way.

I spend my days making sure other people's hearts don't.

I'm a care tech at Vitalis, a longevity clinic off Fifth Avenue South. Our clients are 60, 70, 80. Most of them look my age. Some look younger than me.

Every March I run their Pace. It's a finger-prick and a chip. The number doesn't tell you how old you are. It tells you how fast you're getting there.

A man walked in Monday with a Pace of 0.71. He's 71. His body ages at two-thirds speed. He golfs. He dates. He's going to see 2075.

My mother's Pace was 1.0. Dead on schedule. She never tested it. She said she didn't want to know.

The clinic has three tiers.

Bronze is the monthly shot. The metabolic one. It keeps your blood sugar flat and the weight off. Everybody's on that now. Even me.

Silver adds the clear-outs. They flush the tired old cells out of you… the ones that just sit there and stoke a slow burn inside.

Gold is the Reset. That's the big one. They take a cell and walk it back toward young. Not slower. Younger. Like turning back an odometer.

Gold costs more than my house.

And here's the part nobody tells you. I don't envy the clients. Not exactly. I miss something else.

I miss when everybody aged together.

When I was a girl, a face told the truth. Gray hair meant something. A wrinkle was a receipt for a life. Now a face is a purchase. I can't read anyone anymore.

But I won't pretend it's all loss.

My grandson, Eli, was born with sickle cell. In my mother's day that meant a short, hard life. They fixed him at eleven. One treatment. They pulled his cells, rewrote them, put them back.

He's nineteen now. He runs track. One shot… and a whole future that didn't used to exist.

So I hold both things. The clinic that keeps strangers young. And the cure that saved my boy. Same science. Different door.

I laid my mother to rest in a plain dress. Her hands looked like her hands. Eighty years of them.

I keep thinking she got to be finished. Nobody at Vitalis is ever finished. They just keep buying more time… and paying by the month.

I don't know which of us got the better deal. We'll see.

 
— Dana Whitfield
Naples, Florida
Former hospice nurse
Cellular care tech, Vitalis Longevity
 
◉ Snap back to the present
Dana's letter is fiction. The forces that create her world are not. Every signal in this transmission is already live… in July 2026.
REPROGRAMMING
1st human · June 2026
Dana's "Reset" has a starting gun. On June 9, 2026, a company called Life Biosciences dosed the first human ever with partial epigenetic reprogramming. The therapy, ER-100, uses three genes — OCT4, SOX2, KLF4 — to coax old, damaged cells back toward a younger state. This first trial targets age-related vision loss, not the whole body. But it's the first time anyone has tried the odometer trick in a living person. That's how the future starts. Narrow… then not.
Life Biosciences; GlobeNewswire — 2026
AGING CLOCKS
$349 finger-prick
Dana's "Pace" test is here today. It's called DunedinPACE. A finger-prick reads chemical marks on your DNA and tells you how fast you're aging — not your age, your speed. TruDiagnostic sells it now for about $349. Clinics already use it to check whether someone's anti-aging plan is working. A number for how fast you're wearing out… and a market forming around pushing it down.
TruDiagnostic; The Lancet eBioMedicine — 2026
SENOLYTICS
40–60% less inflammation
The "clear-outs" trace to senolytics — drugs that kill off worn-out "zombie" cells that linger and stoke inflammation. In early trials from Unity Biotechnology and the Mayo Clinic, senolytic compounds cut inflammation markers by 40 to 60% and improved movement in older patients. A cheap combo of two older drugs helped lung-scarring patients too. Still early. Still small. But it's exactly Dana's clinic: pull out the tired cells, and the body runs cleaner.
Unity Biotechnology; Mayo Clinic — 2025–2026
GENE CURES
$2.2M–$3.1M a dose
Eli's one-shot cure is here today, and so is its price. Two FDA-approved gene therapies for sickle cell — Casgevy and Lyfgenia — run $2.2 million and $3.1 million a dose. One treatment. A rewritten future. But the cost tests everything. Medicaid now pays some of these bills only if the cure actually works — outcome-based deals for a one-time fix. That's Dana's whole world in one line: same science, different door.
BioPharma Dive; NPR; Congressional Budget Office — 2026
METABOLIC
$1,000 → $245 / month
The "monthly shot everybody's on" is the GLP-1 story, sped up. These drugs flatten blood sugar and melt weight. List prices ran near $1,000 a month. Now Medicare has them at $245, and a new federal deal puts vials around $350 direct-to-consumer. When a maintenance drug gets cheap enough, it stops feeling like medicine and starts feeling like a habit… Dana's Bronze tier. Millions of people in, and climbing.
CMS; AMCP; eMarketer — 2026
 
That's the transmission for today. Dana is fiction. Her Pace score, the clear-outs, her grandson's cure — already here, or nearly. The old world aged us all at one speed. The new one puts a price on the clock… and we're the ones watching it start. See you tomorrow.
2045
Letters from the transition · Est. 2026